Related Experiment Video
Updated: Oct 6, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic predisposition study of heart failure and its association with cardiomyopathy
Vaishak Kaviarasan1, Vajagathali Mohammed1, Ramakrishnan Veerabathiran2
1Human Cytogenetics and Genomics Laboratory, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamilnadu, 603103, India.
Insights
Genetic factors significantly contribute to heart failure (HF), particularly through cardiomyopathy. Understanding these genetic variants is crucial for developing personalized HF treatments.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Heart failure (HF) is a complex clinical condition involving myocardial structural and functional defects, influenced by genetic and environmental factors.
- The incidence of HF is estimated between 1-2% in developed countries, with genetic factors, especially cardiomyopathy, being a common cause.
- Existing research highlights the heterogeneity and complexity of genetic factors contributing to HF progression.
Purpose of the Study:
- To investigate the association between heart failure (HF) and cardiomyopathy, focusing on their underlying genetic variants.
- To identify novel genes implicated in the pathogenesis and progression of inherited human cardiomyopathy and HF.
- To enhance the understanding of the genetic basis of HF for improved diagnostic accuracy and therapeutic strategies.
Main Methods:
- Literature review and data collection from human gene mutation databases and other relevant research sources.
- Analysis of genetic variants linked to inherited cardiomyopathy.
- Examination of the role of identified genes in the molecular pathophysiology of HF.
Main Results:
- Numerous genes have been identified and linked to cardiomyopathy, confirming a significant hereditary influence on the condition.
- Selected novel genes demonstrate a critical role in the pathogenesis and progression of HF.
- Findings provide robust evidence supporting the genetic underpinnings of HF.
Conclusions:
- Understanding the genetic architecture of HF, particularly its link to cardiomyopathy, is essential.
- The identified genetic variants offer insights into HF etiology and progression.
- Enhanced knowledge of genetically driven HF pathophysiology may pave the way for personalized therapeutic interventions.
Abstract:
Heart failure (HF) is a clinical condition distinguished by structural and functional defects in the myocardium, which genetic and environmental factors can induce. HF is caused by various genetic factors that are both heterogeneous and complex. The incidence of HF varies depending on the definition and area, but it is calculated to be between 1 and 2% in developed countries. There are several factors associated with the progression of HF, ranging from coronary artery disease to hypertension, of which observed the most common genetic cause to be cardiomyopathy. The main objective of this study is to investigate heart failure and its association with cardiomyopathy with their genetic variants. The selected novel genes that have been linked to human inherited cardiomyopathy play a critical role in the pathogenesis and progression of HF. Research sources collected from the human gene mutation and several databases revealed that numerous genes are linked to cardiomyopathy and thus explained the hereditary influence of such a condition. Our findings support the understanding of the genetics aspect of HF and will provide more accurate evidence of the role of changing disease accuracy. Furthermore, a better knowledge of the molecular pathophysiology of genetically caused HF could contribute to the emergence of personalized therapeutics in future.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Cardiomyopathy I: Introduction and Classification
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy

